Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ENW4 | ISIN: US00430H2013 | Ticker-Symbol: 1A80
Stuttgart
12.05.25 | 08:09
0,100 Euro
0,00 % 0,000
1-Jahres-Chart
ACCELERATE DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
ACCELERATE DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0870,08907:32
0,0000,00008.05.

Aktuelle News zur ACCELERATE DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:55XFRA 1A80: AUSSETZUNG/SUSPENSION126DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILACCELERATE DIAGN.NEW...
► Artikel lesen
ACCELERATE DIAGNOSTICS Aktie jetzt für 0€ handeln
08.05.Accelerate Diagnostics, Inc - 8-K, Current Report1
08.05.Accelerate Diagnostics Initiates Chapter 11 Restructuring Proceeding1
08.05.Accelerate Diagnostics leitet Insolvenzverfahren nach Chapter 11 und Vermögensverkauf ein3
08.05.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets89TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate" or the Company") today announced that it has voluntarily...
► Artikel lesen
25.04.Accelerate Diagnostics, Inc - 8-K, Current Report3
15.04.Accelerate Diagnostics, Inc - 8-K, Current Report2
23.03.Accelerate Diagnostics: Umsatzrückgang trotz Verlustreduktion2
21.03.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance355TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today...
► Artikel lesen
21.03.Accelerate Diagnostics beantragt FDA-Zulassung für WAVE-System2
21.03.Accelerate Diagnostics seeks FDA clearance for WAVE system2
21.03.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results188TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today reports financial results for the fourth quarter and year ended...
► Artikel lesen
21.03.Accelerate Diagnostics, Inc - 8-K, Current Report1
21.03.Accelerate Diagnostics reports Q4 results1
10.01.Accelerate Diagnostics reports preliminary FY 2024 revenue of $11.7 million2
10.01.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results262TUCSON, Ariz., Jan. 10, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing...
► Artikel lesen
10.01.Accelerate Diagnostics, Inc - 8-K, Current Report-
04.12.24Hedge Fund and Insider Trading News: George Soros, Ken Griffin, Tiger Management, BlueCrest Capital Management, Pallister Capital, Accelerate Diagnostics Inc (AXDX), CTS Corp (CTS), and More2
07.11.24Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Third Quarter 2024 Financial Results118TUCSON, Ariz., Nov. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September...
► Artikel lesen
30.09.24Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc System458An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR) Enables rapid, automated microbial identification on the Bruker MALDI Biotyper® CA System directly from positive...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1